[Commentary to the article: Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43]
- PMID: 17366371
[Commentary to the article: Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43]
Similar articles
-
[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].Kardiol Pol. 2008 Jun;66(6):705-6; discussion 707. Kardiol Pol. 2008. PMID: 18700309 Polish. No abstract available.
-
[Commentary to the article: Antman EM, Morrow DA, McCabe CH, et al. ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006; 354: 1477-88].Kardiol Pol. 2006 Nov;64(11):1321-4; discussion 1325-6. Kardiol Pol. 2006. PMID: 17165173 Polish. No abstract available.
-
[Commentary to the article: Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38].Kardiol Pol. 2009 Dec;67(12):1417-8. Kardiol Pol. 2009. PMID: 20178156 Polish. No abstract available.
-
Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?Ann Pharmacother. 2007 Jul;41(7):1174-80. doi: 10.1345/aph.1K045. Epub 2007 May 29. Ann Pharmacother. 2007. PMID: 17535842 Review.
-
MR imaging of the small bowel in Crohn's disease.Eur J Radiol. 2009 Mar;69(3):409-17. doi: 10.1016/j.ejrad.2008.11.013. Epub 2008 Dec 31. Eur J Radiol. 2009. PMID: 19118967 Review.
Cited by
-
Atherosclerosis and cardiovascular risk reduction with PPAR agonists.Curr Atheroscler Rep. 2007 Oct;9(4):274-80. doi: 10.1007/s11883-007-0033-4. Curr Atheroscler Rep. 2007. PMID: 18173954 Review.
-
Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents.J Endocrinol Invest. 2008 Apr;31(4):371-9. doi: 10.1007/BF03346373. J Endocrinol Invest. 2008. PMID: 18475058 Review.
-
PPARγ Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice.PPAR Res. 2013;2013:612971. doi: 10.1155/2013/612971. Epub 2013 Dec 30. PPAR Res. 2013. PMID: 24489534 Free PMC article.
-
Potential of glucose-lowering drugs to reduce cardiovascular events.Curr Diab Rep. 2009 Feb;9(1):87-94. doi: 10.1007/s11892-009-0015-8. Curr Diab Rep. 2009. PMID: 19192430 Review.
LinkOut - more resources
Medical